Non-profit receives FDA approval to supply cheaper OTC naloxone
Harm Reduction Therapeutics won FDA approval for the second OTC naloxone nasal spray to treat known or suspected opioid overdose emergencies.
Harm Reduction Therapeutics won FDA approval for the second OTC naloxone nasal spray to treat known or suspected opioid overdose emergencies.
What's Your Reaction?
